ERBB2 and ovarian cancer: Notably, several different ovarian cancer types (including serous, mucinous, and clear-cell epithelial ovarian cancer) are characterised by HER2 overexpression [54], which is associated with higher invasion, chemoresistance, aggressiveness, and overall poor survival [54,55,56].